SYNCAP ONE 150MG TABLET belongs to a class of drugs called 'antiparkinson agents', a precursor of dopamine (chemical messenger in the brain) primarily used in treating Parkinson's disease with its symptoms including tremors, spasms, muscle stiffness and poor muscle control. Parkinson's disease is a disorder of the central nervous system that affects movement and locomotion, which causes stiffness, shaking, and difficulty in walking, coordination and balance. In Parkinson's patients, there are low dopamine levels as the nerve cells of the brain (neurons) that produce dopamine begin to die.

SYNCAP ONE 150MG TABLET contains Carbidopa, Levodopa, and Entacapone. Levodopa belongs to the central nervous system agents, while Carbidopa is a decarboxylase inhibitor. The medicinal component Levodopa changes into dopamine in the brain and helps to control movement. Carbidopa prevents the breakdown of Levodopa in the bloodstream so that more Levodopa can reach the brain. On the other hand, Entacapone belongs to a class of COMT (catechol-o-methyltransferase enzyme) inhibitors which causes higher and more sustained levels of Levodopa in the blood that more Levodopa can reach the brain, leading to greater relief from the symptoms of Parkinson's disease.

Take SYNCAP ONE 150MG TABLET as prescribed by your doctor. You are suggested to take $ame as long as your doctor has prescribed it after checking your medical condition. The most common side effects of SYNCAP ONE 150MG TABLET are nausea, vomiting, loss of appetite, light-headedness, lowered blood pressure, confusion, and dyskinesia (uncontrolled/involuntary muscle movement). Most of these side effects of SYNCAP ONE 150MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are known to be allergic to SYNCAP ONE 150MG TABLET or any other medicines, please tell your doctor. Do not take SYNCAP ONE 150MG TABLET if you are pregnant or breastfeeding unless prescribed by the doctor. SYNCAP ONE 150MG TABLET should not be given to children as safety and effectiveness have not been established. SYNCAP ONE 150MG TABLET may cause hallucinations (seeing or hearing things that are not there) in some cases if taken for a prolonged time. So, if you experience hallucinations while taking SYNCAP ONE 150MG TABLET, please talk to your doctor immediately. Keep your doctor informed about your medicines and health condition and rule out any side effects.

SYNCAP ONE 150MG TABLET is an antiparkinson agent that is used in the treatment of Parkinson’s disease. SYNCAP ONE 150MG TABLET is a combination of three medicines: Carbidopa, Levodopa, and Entacapone. Levodopa belongs to the class of medications name as central nervous system agents, While Carbidopa falls in decarboxylase inhibitors. The medicinal component Levodopa changes into dopamine in the brain and helps to control movement. At the same time, Carbidopa acts by preventing the breakdown of Levodopa in the bloodstream so that more Levodopa can effectively reach the brain to block acetylcholine (a chemical messenger in the brain). Entacapone blocks a certain natural substance, catechol-o-methyltransferase (COMT) (an enzyme that breaks down the levodopa in the body), which causes higher and more sustained levels of levodopa in the blood, so that more Levodopa can reach the brain, leading to greater relief from the symptoms of Parkinson’s disease. This effect allows the levodopa to last longer in the body so that it doesn't wear off before the next dose.

Do not stop taking SYNCAP ONE 150MG TABLET suddenly without talking to your doctor. It may result in a serious neuroleptic malignant syndrome (NMS) that causes fever, muscle cramps or stiffness, unusual body movements, fast heartbeat, sweating, change in thinking, and confusion. Do not take SYNCAP ONE 150MG TABLET if you are allergic to SYNCAP ONE 150MG TABLET or any of its ingredients. Tell your doctor if you have any medical history of diabetes, heart attacks, mental illness, stomach ulcers, heart disease, or have recently undergone a surgical procedure. SYNCAP ONE 150MG TABLET may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position, especially when you start taking SYNCAP ONE 150MG TABLET so please get up gradually. Besides this, a prolonged intake of SYNCAP ONE 150MG TABLET may lead to greater neuropathy chances (nerve damage). SYNCAP ONE 150MG TABLET should be given with caution in patients with eye problems (narrow-angle glaucoma), irregular heartbeat (arrhythmia), gastrointestinal bleeding, and psychosis. The use of SYNCAP ONE 150MG TABLET is restricted if a person takes monoamine oxidase inhibitors (MAOs) or antidepressant drugs like isocarboxazid, phenelzine, selegiline, and tranylcypromine because it can lead to high blood pressure (hypertension) crisis.

• Drink plenty of water to avoid headaches due to dehydration. 
• Limit the consumption of sugar-containing food or food with too many calories but fewer nutrients, as it may cause tooth decay.
• Engaging in physical activity like dancing or exercising will boost the metabolism and make a person more energetic.
• Avoid intake of alcoholic beverages with SYNCAP ONE 150MG TABLET as it can make a person dehydrated and may affect their sleep. This can make it harder for a person’s body to aid the SYNCAP ONE 150MG TABLET in fighting off infections.

• Do not exceed more than 1 dose (2 capsules) for any off period (recurring symptoms in between regular doses).
• If you have unusual urges like gambling, spending money, overeating, or increased sexual urges, please inform your doctor before taking the SYNCAP ONE 150MG TABLET.